Clinical Outcomes in Young Patients Undergoing Percutaneous Coronary Intervention
Isaac Park1, Millie Watkins1, Diem Dinh2
1Department of Cardiology, Royal Melbourne Hospital, Melbourne, Australia.
Summary
Young adults undergoing percutaneous coronary intervention (PCI) have low mortality, but comorbidities like diabetes and kidney disease increase long-term risks. Improved secondary prevention is crucial for these high-risk patients.
Area of Science:
- Cardiology
- Interventional Cardiology
- Public Health
Background:
- Young adults undergoing percutaneous coronary intervention (PCI) are often considered low-risk.
- Limited long-term outcome data exist for this demographic.
- Identifying predictors of adverse events is key to improving care.
Purpose of the Study:
- To determine the incidence and predictors of 12-month mortality.
- To evaluate major adverse cardiovascular events (MACE) within 30 days.
- To analyze a contemporary Australian cohort of young PCI patients.
Main Methods:
- Analysis of data from the Victorian Cardiac Outcomes Registry (VCOR) (2014-2023).
- Inclusion of patients aged 18-55 years undergoing PCI.
- Exclusion of patients with out-of-hospital cardiac arrest or cardiogenic shock.
Main Results:
- 12-month mortality was 1.0% across all age subgroups.
- Predictors of mortality included low eGFR, reduced ejection fraction, diabetes, and female sex.
- Lower dual antiplatelet therapy use, femoral access, and bare-metal stents were noted in deceased patients.
Conclusions:
- 12-month mortality after PCI in young adults is low.
- Comorbidities like diabetes, CKD, and LV dysfunction are linked to worse outcomes.
- Enhanced secondary prevention is vital for high-risk young patients post-PCI.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
220
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
220
Coronary Artery Disease V: Interprofessional Care
215
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
215
Acute Coronary Syndrome III: Diagnostic Studies
218
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
218
Acute Coronary Syndrome I: Introduction
828
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
828
Acute Coronary Syndrome V: Nursing Management
271
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
271
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
363
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
363


